Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeted Therapy With Gefitinib in Patients With USP8-mutated Cushing's Disease

NCT02484755 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT02484755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02484755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeted Therapy With Gefitinib in Patients With USP8-mutated Cushing's Disease
Lead sponsor
Huashan Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2015
Completion date
Not reported
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corticotrophin adenoma, cushing's disease